Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | APEX1 | P27695 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.52 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.52 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.52 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | OGT | O15294 | 2/20 | 0.48 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.45 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20412286 | 0.91 | MEN1 (0.48) | MEN1APEX1KMT2AP2RY14P2RY2 | |
| SCHEMBL24092376 | 0.91 | P2RY14 (0.61) | MEN1APEX1KMT2AP2RY14P2RY2 | |
| SCHEMBL22024013 | 0.91 | P2RY14 (0.61) | MEN1APEX1KMT2AP2RY14P2RY2 | |
| SCHEMBL20415965 | 0.91 | P2RY14 (0.61) | MEN1APEX1KMT2AP2RY14P2RY2 | |
| SCHEMBL22024083 | 0.90 | P2RY14 (0.49) | P2RY14P2RY2P2RY4P2RY6SLC28A1 | |
| SCHEMBL22023504 | 0.90 | P2RY14 (0.49) | P2RY14P2RY2P2RY4P2RY6SLC28A1 | |
| SCHEMBL22023769 | 0.90 | P2RY14 (0.49) | P2RY14P2RY2P2RY4P2RY6SLC28A1 | |
| SCHEMBL22024085 | 0.90 | P2RY14 (0.49) | P2RY14P2RY2P2RY4P2RY6SLC28A1 | |
| SCHEMBL22023505 | 0.90 | P2RY14 (0.49) | P2RY14P2RY2P2RY4P2RY6SLC28A1 | |
| SCHEMBL22023642 | 0.90 | P2RY14 (0.49) | P2RY14P2RY2P2RY4P2RY6SLC28A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024186837-A2 | LIGHT CONTROLLED PROXIMITY LABELING WITH LOV-TURBO | CZ BIOHUB SF, LLC (US) | 2024-09-12 | — | — | WO | disclosed |
| US-20230038373-A1 | STABILE CONJUGATE | GLYKOS BIOMEDICAL OY (FI) | 2023-02-09 | — | — | US | disclosed |
| US-20210402002-A1 | CONJUGATE | GLYKOS BIOMEDICAL OY (FI) | 2021-12-30 | — | — | US | disclosed |
| WO-2021123506-A1 | STABILE CONJUGATE | GLYKOS BIOMEDICAL OY (FI) | 2021-06-24 | — | — | WO | disclosed |
| EP-3810204-A1 | CONJUGATE | Glykos Biomedical Oy (FI) | 2021-04-28 | — | — | EP | disclosed |
| CN-112672764-A | Conjugates | 格莱科斯生物医药公司 | 2021-04-16 | — | — | CN | disclosed |
| WO-2019243672-A1 | CONJUGATE | GLYKOS BIOMEDICAL OY (FI) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210402002-A1 | CONJUGATE | ST6GAL1, CSGALNACT1, FUT6 | MEN1 1645/4885APEX1 2697/4885KMT2A 2980/4885 |
| US-20230038373-A1 | STABILE CONJUGATE | CD2, TTL, DDOST | MEN1 836/4885APEX1 1432/4885KMT2A 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.